BeWhere Holdings (TSX.V: BEW) Price - $0.21 Market Cap - $18.5M

• BeWhere Holdings Inc. Reports 2021 Fiscal Year-End Results

• Q4 Revenue of $2.1M

• Q4 Gross profit of $703K

• Q4 Net income of $177

• FY Revenue $8.5M

• FY Gross profit of $2.28

• FY Net income of $416K

• Press Release https://tinyurl.com/yhsn7ed7

BeWhere continue to grow all operating metrics. We are especially impressed with their growth in hardware sales which is a very good forecaster of future recurring revenue. The stock has pulled back along with most nanocaps. We think the stock offers very good risk/reward at current prices especially for investors with longer term intentions.  

Medexus Pharmaceuticals (TSX: MDP) Price - $3.01 Market Cap - $60M

• Medexus to Present at the Bloom Burton & Co. Healthcare Investor Conference

• Press Release https://tinyurl.com/252c5c6f

• Medexus Pharmaceuticals Announces Resubmission of Treosulfan NDA

• Press Releaseh ttps://tinyurl.com/4dv6htsn

On Friday the company announced that they are resubmitting their new drug submission to the FDA for Treosulfan. This product has very large revenue potential and an FDA approval is expected to dramatically change the outlook for the company. We believe it is still a bit too early to re-enter the stock but feel it makes sense to keep an eye out and be prepared to re-visit this opportunity closer to the expected response date expected in about 6 months.

Atlas Engineered Products (TSX.V: AEP) Price - $0.62 Market Cap - $37M

• Atlas Engineered Products Reports Record 2021 Year End and Fourth Quarter Financial and Operating Results

• Q4 Revenue of $13.89M

• Q4 EBITDA of $4.3M

• Q4 Net income of $2.45M

• FY Revenue of $54.99M

• FY Gross profit of $16M

• FY Net income of $6.95M

• Press Release https://tinyurl.com/2p8fut9h

• Atlas Engineered Products Announces Grant of Options

• Press Release https://tinyurl.com/bdeuj4d3

ImmunoPrecise Antibodies (TSX.V: IPA) Price - $7.36 Market Cap - $173M

• IPA’s Advanced PolyTope® TATX-03, a Multi-Antibody Cocktail, Potently Prevents In Vitro Infection of Cells by the Currently Dominant Omicron Sublineage BA.2, in Addition to all Other Variants of Concern

• Press Release https://tinyurl.com/ejvubbxn

More positive data. Management believes they are the only organization with a single therapeutic that has shown potent neutralizing data against all Covid variants of concern. We expect more data from the company on their Talem pipeline of drug candidates and other updates as the company prepares for its most significant industry conference PEGS 2023 (https://www.pegsummit.com/)

Renoworks Software (TSX.V: RW) Price - $0.35 Market Cap - $14M

• RENOWORKS PRIVATE PLACEMENT OVERSUBSCRIBED; COMPANY RAISES $805,000

• Press Release https://tinyurl.com/2p89ztt8

• RENOWORKS ANNOUNCES FOURTH QUARTER AND RECORD FISCAL YEAR 2021 FINANCIAL RESULTS

• Q4 Revenue of $1.25M

• Q4 Gross margin of 62%

• Q4 Adj. EBITDA loss of ($263K)

• Q4 Net loss of ($360K)

• FY Revenue of $5.53M

• FY Adj. EBITDA loss of ($368K)

• FY Net loss of ($608K)

• Press Release https://tinyurl.com/3pp7pzh2

RIWI Corp (TSX.V: RIWI) Price - $0.90 Market Cap - $16M

• Half of Russians Believe That People Should Support Their Country Even If Its Actions Are Wrong, According to RIWI's New Cold War II Index

• Press Release https://tinyurl.com/82fy4su6

iFabric (TSX: IFA) Price - $2.40 Market Cap - $71M

• iFabric Provides Update on EPA Claims Submission Process

• Press Release https://tinyurl.com/3cdrxm65